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Measurement of renal function in pre-ESRD patients. The toms and signs of uremia, improves survival chances and
measurement of renal function in pre-dialysis patients is impor- reduces morbidity [1]. Apart from the classical parame-
tant in order to determine the appropriate time to begin renal ters for determining the glomerular filtration rate (GFR),replacement therapy, to forecast the start, and to compare, in
over the last few years, new determinations have beengroups of patients, the efficiency of different treatments that
introduced such as the use of iohexol or cystatin C [2],limit renal disease progression. The most reliable methods,
such as inulin clearance or measurement by radioisotopes, are as well as new concepts including the measurement of
too awkward for the usual clinical follow-up of patients. Al- the Kt/V of urea or the evaluation of the nutritional
though much simpler and almost as reliable, the use of iohexol state by means of the protein equivalent of total nitrogenradiologic contrast does not allow the frequent monitoring of
appearance normalized to body weight (nPNA) in thethe patient either. The determinations of the plasmatic creati-
study of pre-dialysis patients [3].nine and its clearance or the estimate of the glomerular filtra-
tion rate by means of equations derived from the creatinine Each one of the tests available used in measuring the
are the methods most often used in order to measure renal GFR, including the referenced technique (inulin clear-
function, although not without problems in pre-dialysis. In
ance), has problems that are even greater in pre-dialysisorder to try to overcome such problems, more precise equations
patients. Therefore, the suitable determination of theand procedures, including the measurement of averaged urea-
creatinine clearance or creatinine clearance with cimetidine, renal function is still a subject of debate. Renal function
have been designed that better estimate the glomerular filtra- as a whole does not mean, exclusively, GFR. Malnutri-
tion rate. However, none of these methods is totally reliable in tion related to uremia and its associated morbimortality
pre-dialysis. A new endogen marker, cystatin C, has advantages
must also be evaluated. Hence, the proposal of theover creatinine, though more studies are needed in pre-dialysis
DOQI guidelines is to use Kt/V and nutritional parame-in order to ascertain its use. The initial proposal of the National
Kidney Foundation’s Kidney Disease Outcome Quality Initia- ters as an indirect measurement of renal function and
tive (DOQI) guidelines to use weekly Kt/V and nutritional in order to determine when to start dialysis [3].
parameters to determine the time for starting renal replace-
ment therapy has widened the prospects of the debate on
the measurement of renal function in pre-dialysis, but further CLEARANCE BY ISOTOPES AND
work is required to define their role in pre-dialysis patients’ RADIOLOGIC CONTRASTSfollow-up.
The use of radioactive isotopes is a more practical
method than that of inulin for calculating the GFR. Mini-
mum differences are observed between the clearancesIn pre-dialysis patients, the exact measurement of re-
(Cl) of these isotopes and that of inulin [4, 5]. Fromnal function is of crucial importance not just for de-
greater to lesser complexity, GFR can be calculated bytermining the right time to start renal replacement ther-
measuring urinary Cl, plasmatic Cl, or from the imagesapy (RRT) but also in order to forecast its start and to
obtained with a gamma camera, the latter method beingcompare, in large series of patients, the efficiency of the
less precise in pre-dialysis patients [6].different treatments permitting reduced renal disease
Radioactive compounds give exact information on theprogression. An early start of dialysis, based exclusively
GFR, but the majority of hospitals do not have accesson objective parameters, before the appearance of symp-
to them. The use of radiologic contrasts such as iohexol
rather than radioactive markers has been proposed in
1 Present address: Nephrology Service, Hospital Valdecilla, 39008 San- order to calculate the renal Cl [7]. The plasmatic Cl
tander, Cantabria, Spain. of iohexol shows excellent correlation with plasmatic
EDTA and inulin clearances [2, 8, 9]. It has also beenKey words: Averaged creatinine-urea clearance, creatinine, creatinine
clearance, cystatin C, Kt/V, nPNA, renal function. shown to be very precise in the group of patients with
moderate-severe renal insufficiency [10]. 2002 by the International Society of Nephrology
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Although the generalization of isotopic techniques, or imprecise. Even in trained patients, the variation in Cr
with radiological contrasts, are advocated by some as elimination because of urine collection problems is be-
the ideal method for measuring GFR [11], in clinical tween 3% and 14%, reaching 70% in untrained patients
practice they are not so simple for quick and repetitive [11, 19]. Greater CCr than plasmatic Cr variation from
use with patients. Use seems more appropriate in clinical day to day indicates which is easier for detecting changes
trials in which treatment for reducing renal disease pro- in the GFR with the Cr [12].
gression is compared. A substantial part of Cr excretion by the kidney is
caused by tubular secretion. In patients with severe renal
insufficiency, up to 60% of urinary Cr comes from tubu-CREATININE
lar secretion [12, 20]. The relationship between fractional
Plasmatic creatinine (Cr) concentration, because of its
excretion of Cr and inulin is greatest between 20 and 25
speed and simplicity, has been used as a usual measure-
mL/min/1.73 m2, varying from 1.2 to 2.1, and it decreasesment of GFR [12]. The main problems with interpreting
in lower or greater values of Cl [20–23]. The bias intro-Cr are chromogenes, extra-renal elimination, and a de-
duced on measuring CCr with regard to that of iothala-crease in muscular mass. The substances called chromo-
mate is approximately 5 mL/min/1.73 m2 for a GFR ofgenes influence the colorimetric reaction that measures
25 mL/min/1.73 m2 [23]. Also, there is marked variabilityplasmatic Cr, falsely increasing its value up to 20% [13].
in the magnitude of Cr secretion in each patient and inIn moderate to severe renal insufficiency, as plasmatic
the same patient throughout the progression of the CRFCr is higher, the chromogenes contribute proportionally
[20], making it impossible to predict the changes in GFRless (5%) [14].
from the changes in the CCr [24].In patients with severe chronic renal failure (CRF), it
For all the above, the measurement of CCr is not usefulhas been shown that an important part of Cr production
in determining the exact level of renal function in pre-is eliminated extra-renally; however, this occurs less of-
dialysis. Some authors advocate that its routine useten in patients with slight to moderate CRF. Estimated
should be abandoned for evaluating CRF progression,extra-renal creatinine clearance in advanced CRF is
given its great variability [11].about 2 mL/min for a person weighing 70 kg. [15]. The
In order to compensate for the tubular secretion ofextra-renal elimination mechanism of Cr in CRF is be-
Cr and the overestimation of GFR by the CCr, two solu-lieved to be caused by degradation inside the intestinal
tions have been proposed: to calculate the Cl as thelight by bacterial flora [16].
The third problem in measuring Cr in CRF is the mean value between the urea and Cr clearances, and to
reduction in its production as the muscular mass de- calculate CCr after reducing the tubular secretion with
creases. When the GFR decreases to 25–50 mL/min, cimetidine. Because the urea is reabsorbed and the urea
patients spontaneously reduce their protein intake [17], clearance underestimates the GFR, it has been suggested
progressively leading to a decrease in the muscular mass, that the mean of urea and Cr clearances may be used
and, therefore, Cr generation [5]. So, plasmatic Cr is less as the measurement of GFR in patients with CRF. This
than that expected for GFR. calculation does not have physiologic support and is sub-
Regarding the patient’s nutritional status and renal ject to greater variability (four determinations), as well
function, plasmatic Cr has two facets. As an expression as the problems in collecting urine. Nevertheless, Lu-
of renal function, the higher this is the more it is associ- bowitz et al have shown that it can serve as a precise
ated with the appearance of uremic symptoms. On the measurement of GFR in advanced CRF, correlating this
other hand, Cr reflects muscular mass. Patients with Cr with the clearance of inulin in patients with GFR  20
under 10 mg/dL at the start of dialysis showed a greater mL/min/1.73 m2 [25], and confirmed by other authors
mortality rate [18]. [5]. In patients with GFR 15 mL/min/1.73 m2 the mea-
Because of the above problems, the measurement of surement of the averaged clearances of urea and Cr more
plasmatic Cr does not precisely determine renal function
precisely estimates GFR [26].
in moderate to severe CRF.
In order to cancel the tubular secretion of Cr and thus
avoid one of the sources of overestimating GFR in pre-
CREATININE CLEARANCE dialysis, oral administration of cimetidine, an organic
cation like Cr that competitively reduces its secretion,The measurement of creatinine clearance (CCr) re-
has been proposed [27]. With cimetidine, the ratio be-solves the problem of variability in the muscular mass,
tween CCr and GFR approaches unity [20, 28, 29]. Soalthough it has other drawbacks: the collection of urine
far, only a limited number of patients have been studiedand the variation in the tubular secretion, which may
using this method, and the dose and guidelines have notoverestimate or underestimate the GFR.
The incorrect collection of urine makes CCr calculation been determined.
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Table 1. Equations
Cockroft-
Gault Cl creatinine (mL/min)  [140  age (years)]  weight (kg)/ [72  Cr (mg/dL)] multiply by 0.85 if female
MDRD7 GFR (mL/min/1.73 m2)  170  Cr (mg/dL)(0.999)  age(0.176)  (0.762 if female)  (1.18 if black)  BUN (mg/dL)(0.170) 
Alb (g/dL)(0.318)
AASK GFR (mL/min/1.73 m2)  222  Cr (mg/dL)(0.974)  age(0.267)  (0.757 if female)  BUN (mg/dL)(0.108)  Alb (g/dL)(0.372)
Nankivell GFR (mL/min)  6.7/Cr (mmol/L)  body weight (kg)/4  urea (mmol/L)/2  100/height (m)2  35 (male) or 25 (female)
Weekly Kt/V Weekly Kt/V Daily urea clearance (L/day)  7 / vol (L)
NPNA (g/kg/day)  [6.49  urine urea nitrogen (g/day)  0.294 (g/L/day)  vol (L)]/[vol (L)]/0.58 (L/kg)]
ESTIMATION OF GFR BY FORMULAS In renal transplant patients, Nankivell et al developed
an equation (Table 1), which includes the value of plas-DERIVED FROM PLASMATIC CREATININE
matic urea, with good correlation in all ranges of renalDifferent studies have shown the imprecision of CCr
function compared with the GFR calculated with 99Tc-to measure GFR, being more precise using equations
DTPA, especially at low levels of GFR. This is beingobtained from the plasmatic Cr [26, 30]. All developed
used in some transplant clinical trials, but its use has notequations consider the opposite of plasmatic Cr as the
become generalized, nor evaluated in other situationsmost important independent variable for calculating the
with CRF [36].GFR. [26]. The formulas include the weight, height, sex,
In general, in developing all these formulas, the moreage, race, and other variables multiplied by different
parameters taken into consideration, the greater the cor-correction factors [12]. These formulas are based on the
relation with the GFR, which gives us an idea of theidea that the excretion of Cr is constant and equal to its
complexity of the work and of the multiple factors influ-production, which, in turn, is proportional to muscular
encing GFR.mass, and can be estimated from other variables [12]. In
pre-dialysis patients with edemas, it is foreseeable that
because of the increase in weight, GFR is overestimated CYSTATIN C
with these formulas in a similar way to cirrhotic patients
Given the problems of plasmatic Cr, other endogen[31].
markers are being sought, the measurement of which inThe simplest formula, and the most used, is that of
plasma will make it possible to know GFR. AlthoughCockroft and Gault (Table 1). This equation was de-
beta2-microglobulin increases progressively according tosigned to calculate CCr in patients without renal disease the decrease in renal function, its production is increased[32]. Although showing a good correlation with the GFR
in certain pathologies, so generalized use in CRF hascalculated with isotopes (0.84), it overestimates the GFR
been ruled out [37].in the low values and shows a great dispersion of the
Cystatin C could be the ideal marker. It is produceddata and a high variability [30, 33, 34].
by the nucleated cells at a constant rate; it filters freelyFrom the study “Modification of Diet in Renal Disease
in the glomeruli and is reabsorbed only to be totallyStudy” (MDRD) several equations have been developed
metabolised on a tubular level. Its production is unaf-in order to predict GFR and have been verified in a
fected by inflammatory or malign processes and is notlarge number of patients with diverse degrees of CRF.
muscular mass- or sex-dependent. Progressively simplerThe most practical formula is number 7 (Table 1), which
methods are being developed for its determination [2,does not involve urine collection and includes demo-
38, 39]. Plasmatic cystatin C correlates well and linearlygraphic and seric factors like albumin, the Cr and the
with the GFR, so that it is more sensitive than Cr forurea. Despite this, it was more precise for estimating the
detecting slight alterations in the GFR [40]. Cystatin CGFR than the CCr measured or estimated by Cockroft
shows greater diagnostic precision than Cr (sensitivity[26]. In the sub-group of patients with serum Cr greater
94%, specificity 95% vs. 94% and 80%) [41], althoughthan 2.5 mg/dL, precision was maintained for predicting
not confirmed in all studies and may not be generalizedthe GFR. The equation has later been validated in pre-
for all kinds of patients [42].dialysis patients and in renal transplant patients [26].
Additional studies are needed on patients with differ-In the group of African American patients included
ent degrees of renal function, in order to find out pre-in the AASK study (African-American Study of Hyper-
cisely the normal and pathologic levels of plasmatic cys-tension and Kidney Disease), the formula derived from
tatin C. Although having the obvious advantage ofthe MDRD study predicted the GFR measured by I125-
increasing in initial stages of renal insufficiency (whichIothalamate better than the CCr and the formula of Cock-
would lead, for example, to the indication of therapiesroft-Gault, although an even more precise formula was
or an earlier renal biopsy), it may not pose any benefitderived from this study for predicting GFR in black
patients and with the same variables (Table 1) [35]. in pre-dialysis patient follow-up [43].
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Fig. 1. Relationships of measured creatinine clearance (A), Cockroft-Gault equation (B), and MDRD-7 equation (C) to weekly Kt/V in pre-
ESRD patients. Regression lines are represented by solid lines. N  1608 measurements of creatinine clearance and Cockroft-Gault. N  321
measurements of MDRD-7.
KT/V
From a practical point of view, we could choose an-
other focus for measuring renal function and deciding
on the start of substitute renal treatment. In 1995, Tatter-
sall et al proposed the use of Kt/V, based on urea kinetic
model and well-established as a useful method for de-
termining the efficiency of dialysis, in order to decide the
ideal time for starting RRT [44]. It is easy to determine in
pre-dialysis patients: All that is needed is to know the
daily urea elimination in order to calculate its clearance
(K), the urea volume distribution (V), according to the
Watson formulas [45], and apply the time (t) in which
we wish to express it (daily or weekly) (Table 1).
The relationship between the seriousness of the clini-
cal signs of uremia and the classical parameters of renal Fig. 2. Relationship of plasmatic creatinine to weekly Kt/V (weekly
function like plasmatic Cr, urea, or CCr is low [46]. On Kt/V  2.5). Regression lines are represented by solid lines. N  968
measurements.the other hand, in the study by Tattersall, Kt/V corre-
lated better than Cr or urea with the mortality, the hospi-
talization rate, and the number of days admitted; hence,
the possible predictive role of the determination of Kt/V well as in the sub-group with Kt/V less than 2.5 (968
pre-dialysis [44]. determinations, r0.52, P 0.000), unlike the results
In our out-patient population with clearances less than published earlier by Tattersall and Kuhlmann in a lesser
30 mL/min/1.73 m2 (1608 determinations in 214 women number of patients [44, 47], though with the same disper-
and 359 men, age range from 17 to 91 years), we have sion of data. (Cr range for Kt/V less than 2.5 of 1 to 16.7
found that the measurement of weekly Kt/V correlates mg/dL, average 5.5  2.4) (Fig. 2).
significantly with CCr (r  0.614, P  0.000), with those As well as having a good correlation with the usual
calculated with the Cockroft formula (r  0.477, P  parameters for measuring renal function, does Kt/V cor-
0.000), and MDRD-7 (321 determinations, r 0.247, P relate with nutritional parameters? In the studies by Meh-
0.000) and, obviously by the mathematical relationship, rotra et al and by Jansen et al, no correlation was found
with urea Cl (r  0.982, P  0.000) and mean urea-CCr between weekly Kt/V and plasmatic albumin, prealbu-
(r 0.856, P 0.000) (Fig. 1). In the study by Kuhlmann min, cholesterol, transferrin, body mass index, and in
et al, in 116 determinations Kt/V did not correlate with the subjective global assessment score (SGA). The only
the Cockroft clearance and only slightly with CCr (r  nutritional parameter with any correlation was nPNA,
0.183, P  0.000) [47]. Our findings are similar to those to which it is linked mathematically [48, 49]. In the study
obtained by Mehrotra et al (Correlation Kt/V-CCr, r  by Caravaca et al, the CCr, the averaged urea-CCr, and
0.78, P  0.01) [48]. Also, we found a significant inverse the Kt/V were compared in relation to a uremic score
correlation between plasmatic Cr and Kt/V, both in the made up of uremic symptoms, SGA, serum albumin, and
total of patients with clearances lower than 30 mL/min/ protein catabolism rate normalized for the ideal body
weight in 201 patients checked in pre-dialysis consulta-1.73m2 (1608 determinations, r  0.536, P  0.000), as
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tion. The averaged Cl and that of the CCr correlated averaged clearance but does not correlate with the nutri-
tional parameters, and its measurement can vary in rela-better with any degree of malnutrition and with the ure-
mic score than with Kt/V [50]. In our group of patients tion to the V. Also, Kt/V has been related to the morbi-
mortality after the start of RRT in a small group ofwith clearances lower than 30 mL/min/1.73 m2 (354 deter-
minations), we found that plasmatic albumin did not patients. At present, the patients are starting RRT well
below the ideal objective of Kt/V of 2 (UK 1.05, USAcorrelate with Kt/V (r  0.098, P  0.065) but did so
with the CCr (r  0.138, P  0.010), averaged Cl (r  and Canada 0.7) [44, 51]. To assume the criteria of Kt/V
2 for the start of the RRT would mean beginning be-0.141, P  0.008), and Cockroft (r  0.228, P  0.000).
What would the appropriate Kt/V value be for starting tween 4 and 20 months before what is usual, with all this
implies [53]. Larger and prospective studies are neededRRT? The DOQI guidelines propose a weekly renal
Kt/V of 2 as the threshold for starting dialysis [3]. It is on the influence of Kt/V use when following up patients
with advanced CRF before its use can be generalized.assumed, therefore, that the risk of morbimortality in
patients without dialysis with Kt/V less than 2 is similar
to that of patients in continuous ambulatory peritoneal
NUTRITIONAL STATE
dialysis (CAPD) unsuitably treated [51]. However, this
Over the past few years, the idea that the seriousnessrecommendation is based on indirect evidence and un-
of the uremia should be evaluated by its deleteriouscontrolled clinical data.
effect on the nutritional state in pre-dialysis patients hasAccording to the NKF-DOQI guidelines for a weekly
gained support, centered on the relationship betweenKt/V of 2, an averaged urea-CCr of 10.5 mL/min/ 1.73 m2
protein intake and renal function [54]. The formulascorrelates [52]. We examined Kt/V sensitivity and speci-
that best predict GFR include nutritional parametersficity for detecting an averaged clearance less than 10.5
reflecting protein intake such as plasmatic albumin ormL/min/1.73 m2 in our group of determinations (N 
urine urea elimination [26]. The risk of malnutrition in-1608). There were 584 cases with averaged clearance
creases as the renal function decreases, because of lowerless than or equal to 10.5 mL/min/1.73 m2, of which 494
protein intake [17]. Patients with hypoalbuminemia atshowed Kt/V less than or equal to 2. Of the 1024 with
the start of dialysis were found to be at higher mortalityaveraged clearance between 10.5 and 30 mL/min/1.73
risk [18]. Although the most important nutritional pa-m2, there were 851 with Kt/V greater than 2. Sensitivity
rameter in the studies is albumin, diverse factors influ-was 84.5%, specificity 83.1%, and the positive predictive
ence this, thereby limiting its use as a nutritional markervalue was 74.0%. Such moderate sensitivity and specific-
[54].ity conform with the correlation shown of Kt/V with the
nPNA (Table 1) has emerged as a useful and reproduc-classical GFR determinations. Kuhlmann et al found a
ible marker in patients with CRF [55]. Protein intake isgreater specificity (91.9%) and lower sensitivity (73.6%),
an excellent marker of nutritional state, assuming thebut in a smaller number of tests [47].
patient is not on a low-protein diet. Initial recommenda-However, Kt/V determination is also subject to errors,
tions by the NKF-DOQI are to start dialysis when nPNAon the one hand those deriving from urine collection,
is less than 0.8 g/kg/day [3], although this recommenda-and on the other, those related to the calculation of the
tion does not appear in the revised version [52]. Theurea volume distribution. Kt/V is greater in women than
nPNA value of 0.8 was derived from studies on patientsin men in different GFR ranges (averaged clearance
in CAPD [56]. Mehrotra et al showed that in patients5 mL/min/1.73 m2: KT/V 1.31  0.25 vs. 1.09  0.19,
with continuous clearances (CAPD and pre-dialysis), aP  0.001; averaged clearance 5–10 mL/min/1.73 m2:
weekly Kt/V of 2 is required in order to maintain anKt/V 2.22  0.41 vs. 1.83  0.38, P  0.0001), which
nPNA of 0.9 g/kg/day [48], although this ratio may notwould suggest that it varies with V [50]. Patients with
be extended to other populations [49]. The recommenda-greater Kt/V generally have less urea distribution volume,
tions in the DOQI guidelines cannot be directly appliedindependent of height, weight, age, and body surface area.
to other countries without further studies.Therefore, a patient with advanced CRF, undernourished
In previous studies, nPNA measurement correlatesand with low weight, could appear with higher Kt/V than
with the GFR measured as averaged urea CCr (r  0.51,that corresponding to him for his clearance, because of
P 0.0001 and r 0.74) [49, 50]. In our group of patientsthe decrease in V. On the other hand, an asymptomatic
with clearance less than 30 mL/min/1.73 m2 (1608 deter-man, well-nourished with a clearance between 10 and
minations), we found a correlation between nPNA and20 mL/min/1.73 m2, could have a Kt/V  2. [47].
the averaged clearance (r  0.586, P  0.000) and theAlthough the DOQI guidelines propose the use of
CCr (r  0.511, P  0.000) (Fig. 3) The use of nPNAKt/V for monitoring the start of the RRT [3] do they
under 0.8 g/kg/day to detect decreases in averaged Clprovide anything more than the classic measurements of
under 10.5 mL/min/1.73 m2 shows low sensitivity (44.1%)the GFR? Kt/V correlates well with GFR and has a
moderate sensitivity and specificity for predicting the but good specificity (87.7%).
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Fig. 3. Relationships of averaged creatinine-
urea clearance (A), and creatinine clearance
(B) to nPNA in pre-ESRD patients. Regres-
sion lines are represented by solid lines. N 
1608 measurements.
Larger, prospective, and well-controlled studies are function in order to reduce the morbimortality of pa-
tients.needed in order to determine the use of nPNA measure-
ment in the follow-ups of pre-dialysis patients and their
Reprint requests to Emilio Rodrigo, M.D. Nephrology Service, Hos-
correlation with mortality and morbidity after the start pital Valdecilla, 39008 Santander, Cantabria, Spain.
E-mail: nefrce@humv.esof the RRT.
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